The University of Chicago Header Logo

Connection

Mark Lingen to Male

Back to Details
This is a "connection" page, showing publications Mark Lingen has written about Male.
Mark Lingen
Connection Strength
0.417
Male
  1. Validation of LOH profiles for assessing oral cancer risk. Cancer Prev Res (Phila). 2012 Sep; 5(9):1075-7.
    View in: PubMed
    Score: 0.019
  2. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013 Jan; 49(1):1-8.
    View in: PubMed
    Score: 0.019
  3. Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prev Res (Phila). 2011 Sep; 4(9):1350-2.
    View in: PubMed
    Score: 0.018
  4. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prev Res (Phila). 2009 Apr; 2(4):385-93.
    View in: PubMed
    Score: 0.015
  5. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol. 2006 May; 28(5):1113-9.
    View in: PubMed
    Score: 0.012
  6. Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India. Int J Cancer. 2026 Mar 15; 158(6):1517-1527.
    View in: PubMed
    Score: 0.012
  7. Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation. Head Neck Pathol. 2025 Sep 12; 19(1):109.
    View in: PubMed
    Score: 0.012
  8. Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA. Oral Oncol. 2025 Aug; 167:107445.
    View in: PubMed
    Score: 0.012
  9. Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
    View in: PubMed
    Score: 0.011
  10. Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas. Oral Oncol. 2025 Apr; 163:107207.
    View in: PubMed
    Score: 0.011
  11. Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan. Oral Oncol. 2025 Mar; 162:107210.
    View in: PubMed
    Score: 0.011
  12. Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab. Cancer Gene Ther. 2024 Oct; 31(10):1477-1485.
    View in: PubMed
    Score: 0.011
  13. Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
    View in: PubMed
    Score: 0.011
  14. Inflammatory Tongue Conditions and Risk of Oral Tongue Cancer Among the US Elderly Individuals. J Clin Oncol. 2024 May 20; 42(15):1745-1753.
    View in: PubMed
    Score: 0.010
  15. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
    View in: PubMed
    Score: 0.009
  16. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 2001 Jun 15; 97(12):3919-24.
    View in: PubMed
    Score: 0.009
  17. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001 May; 13(3):176-82.
    View in: PubMed
    Score: 0.009
  18. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020 10 01; 112(10):1047-1054.
    View in: PubMed
    Score: 0.008
  19. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000 Jul; 22(4):328-35.
    View in: PubMed
    Score: 0.008
  20. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma. Head Neck Pathol. 2020 Dec; 14(4):889-898.
    View in: PubMed
    Score: 0.008
  21. Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma. Cancer Lett. 2020 02 28; 471:49-60.
    View in: PubMed
    Score: 0.008
  22. Immune profiles in primary squamous cell carcinoma of the head and neck. Oral Oncol. 2019 09; 96:77-88.
    View in: PubMed
    Score: 0.008
  23. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897.
    View in: PubMed
    Score: 0.008
  24. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol. 2019 02 01; 30(2):297-302.
    View in: PubMed
    Score: 0.007
  25. Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy. Lab Invest. 2019 09; 99(9):1400-1413.
    View in: PubMed
    Score: 0.007
  26. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma. Histopathology. 2019 Jan; 74(2):321-331.
    View in: PubMed
    Score: 0.007
  27. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3).
    View in: PubMed
    Score: 0.007
  28. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Adv. 2018 01 23; 2(2):146-150.
    View in: PubMed
    Score: 0.007
  29. The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activation. Carcinogenesis. 1997 Feb; 18(2):329-38.
    View in: PubMed
    Score: 0.006
  30. Solitary intraoral keratoacanthoma: report of a case. J Oral Maxillofac Surg. 1996 Aug; 54(8):1026-30.
    View in: PubMed
    Score: 0.006
  31. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):21-9.
    View in: PubMed
    Score: 0.006
  32. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
    View in: PubMed
    Score: 0.006
  33. The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics. 2015 Dec 18; 16:1076.
    View in: PubMed
    Score: 0.006
  34. Obtaining a genetic diagnosis in a child with disability: impact on parental quality of life. Clin Genet. 2016 Feb; 89(2):258-66.
    View in: PubMed
    Score: 0.006
  35. Primary ectopic meningioma of the maxillary sinus: case report and review of the literature. Head Neck. 1995 May-Jun; 17(3):258-62.
    View in: PubMed
    Score: 0.006
  36. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Lett. 2015 Apr 10; 359(2):269-74.
    View in: PubMed
    Score: 0.006
  37. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma. Oral Oncol. 2015 Jan; 51(1):53-8.
    View in: PubMed
    Score: 0.005
  38. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41.
    View in: PubMed
    Score: 0.005
  39. CD84 is markedly up-regulated in Kawasaki disease arteriopathy. Clin Exp Immunol. 2014 Jul; 177(1):203-11.
    View in: PubMed
    Score: 0.005
  40. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.005
  41. Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression. Oral Dis. 2014 Apr; 20(3):e76-80.
    View in: PubMed
    Score: 0.005
  42. Unusual presentation of a chondromyxoid fibroma of the mandible. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol. 1993 May; 75(5):615-21.
    View in: PubMed
    Score: 0.005
  43. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncol. 2013 Jun; 49(6):525-33.
    View in: PubMed
    Score: 0.005
  44. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76.
    View in: PubMed
    Score: 0.005
  45. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012 Jul; 36(7):945-54.
    View in: PubMed
    Score: 0.005
  46. A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Apr 15; 18(8):2336-43.
    View in: PubMed
    Score: 0.005
  47. Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants? Clin Genet. 2013 Jan; 83(1):53-65.
    View in: PubMed
    Score: 0.005
  48. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):664-72.
    View in: PubMed
    Score: 0.005
  49. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clin Cancer Res. 2011 Aug 15; 17(16):5257-67.
    View in: PubMed
    Score: 0.004
  50. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2010 Jul 10; 28(20):3336-43.
    View in: PubMed
    Score: 0.004
  51. Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. J Cell Physiol. 2006 May; 207(2):553-61.
    View in: PubMed
    Score: 0.003
  52. Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clin Cancer Res. 2005 Nov 15; 11(22):8105-8.
    View in: PubMed
    Score: 0.003
  53. Acellular dermal matrix allografts to achieve increased attached gingiva. Part 1. A clinical study. J Periodontol. 2000 Aug; 71(8):1297-305.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.